Activation of skeletal muscle FAPs by LPA requires the Hippo signaling via the FAK pathway-Reference-Cited by-同舟云学术

Activation of skeletal muscle FAPs by LPA requires the Hippo signaling via the FAK pathway

Published:2023-05 Issue: Volume:119 Page:57-81
ISSN:0945-053X
Container-title:Matrix Biology
language:en
Short-container-title:Matrix Biology

Author:

Cruz-Soca Meilyn^ORCID,Faundez-Contreras Jennifer,Córdova-Casanova Adriana^ORCID,Gallardo Felipe S.^ORCID,Bock-Pereda Alexia^ORCID,Chun Jerold^ORCID,Casar Juan Carlos^ORCID,Brandan Enrique^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology

Reference104 articles.

1. LPA receptors: subtypes and biological actions;Choi;Annu. Rev. Pharmacol. Toxicol.,2010

2. Lysophospholipid Receptors;Fukushima;Annu. Rev. Pharmacol. Toxicol.,2001

3. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production;Umezu-Goto;J. Cell Biol.,2002

4. Lipid phosphate phosphatases and signaling;Brindley;J. Lipid Res.,2009

5. Lysophosphatidic acid possesses dual action in cell proliferation;Tigyi;Proc. Natl. Acad. Sci.,1994

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of lysophosphatidic acid-LPA1-YAP signaling in healthy and pathological FAPs migration;Matrix Biology;2024-11

2. LPA-induced expression of CCN2 in muscular fibro/adipogenic progenitors (FAPs): Unraveling cellular communication networks;Matrix Biology;2024-06

3. Targeting AQP9 enhanced the anti-TNF therapy response in Crohn's disease by inhibiting LPA-hippo pathway;Pharmacological Research;2024-05

4. Lysophosphatidic Acid/Polydopamine-Modified nHA Composite Scaffolds for Enhanced Osteogenesis via Upregulating the Wnt/Beta-Catenin Pathway;ACS Applied Materials & Interfaces;2024-03-06